Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A U Engela

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|July 8, 2011
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapiesM J Hoogduijn, M Roemeling-van Rhijn, S S Korevaar, et al.
Clinical and Experimental Immunology|September 14, 2013
Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cellsA U Engela, C C Baan, N H R Litjens, et al.
Clinical and Experimental Immunology|April 24, 2013
Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNAA U Engela, M J Hoogduijn, K Boer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|July 8, 2011
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapiesM J Hoogduijn, M Roemeling-van Rhijn, S S Korevaar, et al.
Clinical and Experimental Immunology|September 14, 2013
Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cellsA U Engela, C C Baan, N H R Litjens, et al.
Clinical and Experimental Immunology|April 24, 2013
Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNAA U Engela, M J Hoogduijn, K Boer, et al.
Pageof 1